Alaunos Therapeutics financial statements

알라우누스 테라퓨틱스NASDAQ:TCRT · Nasdaq · Healthcare · sector #17
$0.7425-6.64%
2026-10-06 close

Alaunos Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$5M.

Reported results

Alaunos Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy